Serum free light chains and multiple myeloma: Is it time to extend their application?. Issue 4 (6th March 2020)

• Record Type: Journal Article
• Authors: Markovic, Uros; Leotta, Valerio; Tibullo, Daniele; Giubbolini, Rachele; Romano, Alessandra; Del Fabro, Vittorio; Parrinello, Nunziatina Laura; Cannizzaro, Maria Teresa; Di Raimondo, Francesco; Conticello, Concetta
• Is Part Of: Clinical case reports. Volume 8:Issue 4(2020)
• Page Start: 617
• Page End: 624
• Publication Date: 2020-03-06
• Subjects: disease progression -- extramedullary relapse -- multiple myeloma -- serological markers -- serum free light chains; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.2636
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: In nonsecretory, oligo‐secretory, and light chain multiple myeloma patients, serial sFLC evaluation could precede biochemical and clinical disease progression, even in extramedullary relapse, thus initiating early treatment with novel anti‐MM agents. Abstract : In nonsecretory, oligo‐secretory, and light chain multiple myeloma patients, serial sFLC evaluation could precede biochemical and clinical disease progression, even in extramedullary relapse, thus initiating early treatment with novel anti‐MM agents.